Literature DB >> 12856464

Making the Health Insurance Flexibility and Accountability (HIFA) waiver work through collaborative governance.

Barbara J Zabawa1.   

Abstract

This paper argues that collaborative governance should be an essential component in any HIFA waiver proposal, due to the fact that the health care system is moving away from a federal and hierarchical program design and implementation towards a more local, collaborative approach. As several current collaborative projects demonstrate, collaboration may overcome barriers to health expansion program success, such as stakeholder buy-in, notice, and state access to private health coverage information. Furthermore, collaboration within the context of the HIFA waiver process may maximize the strengths of current collaborations, such as providing: (a) access to greater and more stable funding sources; (b) access to a facilitator that can collect and distribute data; and (c) an avenue for accountability. Multiple challenges in ensuring collaborative governance are reviewed. Ms. Zabawa argues that these challenges are not insurmountable if states adopt a truly collaborative approach to designing and implementing programs under the HIFA waiver; there may be hope in expanding and improving health coverage, since collaboration is the most appropriate mechanism to address the complexity of health system reform.

Mesh:

Year:  2003        PMID: 12856464

Source DB:  PubMed          Journal:  Ann Health Law


  3 in total

1.  The effect of HIFA waiver expansions on uninsurance rates in adult populations.

Authors:  Adam Atherly; Bryan E Dowd; Robert F Coulam; Gery Guy
Journal:  Health Serv Res       Date:  2012-02-02       Impact factor: 3.402

2.  Medicaid Expansions and Crowd-Out: Evidence from HIFA Premium Assistance Programs.

Authors:  Adam Atherly; Kathleen Call; Robert Coulam; Bryan Dowd
Journal:  Health Serv Res       Date:  2015-05-18       Impact factor: 3.402

3.  Shared health governance.

Authors:  Jennifer Prah Ruger
Journal:  Am J Bioeth       Date:  2011-07       Impact factor: 11.229

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.